as on November 5, 2025 at 12:39 am IST
Day's Low
Day's High
2.26%
Downside
6.04%
Upside
52 Week's Low
52 Week's High
39.25%
Downside
232.45%
Upside
Check Qualigen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.8M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.45
Industry PE ratio
0PEG Ratio
0EBITDA
-6.9M
Revenue (TTM)
5.0M
Profit Margin
0.00%
Return On Equity TTM
-841.66%
Track how Qualigen Therapeutics Inc P/E has moved over time to understand its valuation trends.
Qualigen Therapeutics Inc in the last 5 years
Lowest (-98.55x)
December 31, 2021
Industry (0.00x)
November 4, 2025
Today (0.45x)
November 4, 2025
Highest (182.95x)
September 30, 2021
Today’s Price to Earnings Ratio: 0.45x
Compare market cap, revenue, PE, and other key metrics of Qualigen Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.8M | -99.85% | 0.45 | 0.00% | |
| BUY | $39.7B | 455.58% | -16.34 | -264.83% | |
| BUY | $60.2B | 211.18% | 1425.12 | 1.36% | |
| BUY | $109.1B | 98.06% | 30.31 | 31.86% | |
| BUY | $68.5B | 9.39% | 15.62 | 32.13% |
The Qualigen Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Qualigen Therapeutics Inc investment value today
Current value as on today
₹58,123
Returns
Returns from Qualigen Therapeutics Inc Stock
Dollar Returns*
₹5,648 (+5.65%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Qualigen Therapeutics Inc. Average target price of $5
Get share price movements and forecasts by analysts on Qualigen Therapeutics Inc.
What analysts predicted
47%UPSIDE
Target Price
$5
Current Price
$2.65
Analyzed by
7 Analysts
Target
$5.00
Qualigen Therapeutics Inc target price $5, a slight upside of 47% compared to current price of $2.65. According to 7 analysts rating.
Search interest for Qualigen Therapeutics Inc Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 September
Mon, 06:29 AM
-Faraday Future's YT Jia invests $4 million in Qualigen Therapeutics, acquiring about 7% of common stock.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 923.2% return, outperforming this stock by 1020.6%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 173.5% return, outperforming this stock by 217.9%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter
Price Dip
![]()
In the last 1 month, QLGN stock has moved down by -46.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -855.82K → -1.68M (in $), with an average decrease of 96.9% per quarter
| Organisation | Qualigen Therapeutics Inc |
| Headquarters | 5857 Owens Avenue, Carlsbad, CA, United States, 92008 |
| Industry | Health Technology |
| CEO | Mr. Kevin A. Richardson II |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Koti Meka | Chief Financial Officer |
Mr. Kevin A. Richardson II | Co-CEO, Chief Accounting Officer & Chairman of the Board |
Mr. Robert W. Campbell Becher | President |
Mr. Michael S. Poirier | Chief Operating Officer |
Mr. Christopher L. Lotz | VP of Finance & Corporate Secretary |
Mr. Jiawei Wang | Co-Chief Executive Officer |
Qualigen Therapeutics Inc share price today is $2.65 as on . Qualigen Therapeutics Inc share today touched a day high of $2.81 and a low of $2.59.
Qualigen Therapeutics Inc share touched a 52 week high of $8.81 on and a 52 week low of $1.61 on . Qualigen Therapeutics Inc stock price today i.e. is trending at $2.65,which is 69.92% down from its 52 week high and 64.60% up from its 52 week low.
Qualigen Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Qualigen Therapeutics Inc (QLGN) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Qualigen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Qualigen Therapeutics Inc share’s latest price of $2.65 as on November 5, 2025 at 12:39 am IST, you will get 3.7736 shares of Qualigen Therapeutics Inc. Learn more about
fractional shares .
Qualigen Therapeutics Inc stock has given -99.85% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?